BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 23731423)

  • 1. Substance use disorders and HIV/AIDS prevention and treatment intervention: research and practice considerations.
    Campbell AN; Tross S; Calsyn DA
    Soc Work Public Health; 2013; 28(3-4):333-48. PubMed ID: 23731423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Motivating HIV positive women to adhere to antiretroviral therapy and risk reduction behavior: the KHARMA Project.
    Holstad MM; DiIorio C; Magowe MK
    Online J Issues Nurs; 2006 Jan; 11(1):5. PubMed ID: 16629499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Provision of onsite HIV Services in Substance Use Disorder Treatment Programs: A Longitudinal Analysis.
    Aletraris L; Roman PM
    J Subst Abuse Treat; 2015 Oct; 57():1-8. PubMed ID: 25934459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptation and National Dissemination of a Brief, Evidence-Based, HIV Prevention Intervention for High-Risk Men Who Have Sex with Men.
    Herbst JH; Raiford JL; Carry MG; Wilkes AL; Ellington RD; Whittier DK
    MMWR Suppl; 2016 Feb; 65(1):42-50. PubMed ID: 26916033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A social systems analysis of implementation of El Salvador's national HIV combination prevention: a research agenda for evaluating Global Health Initiatives.
    Dickson-Gomez J; Glasman LA; Bodnar G; Murphy M
    BMC Health Serv Res; 2018 Nov; 18(1):848. PubMed ID: 30419904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrating HIV prevention activities into the HIV medical care setting: a report from the NYC HIV Centers Consortium.
    Wilson TE; Vlahov D; Crystal S; Absalon J; Klein SJ; Remien RH; Agins B
    J Urban Health; 2006 Jan; 83(1):18-30. PubMed ID: 16736352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV/AIDS and homelessness, Part 1: background and barriers to care.
    Douaihy AB; Stowell KR; Bui T; Daley D; Salloum I
    AIDS Read; 2005 Oct; 15(10):516-20, 527. PubMed ID: 16265767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of psychoeducation for HIV risk reduction.
    Malow RM; West JA; Corrigan SA; Pena JM; Cunningham SC
    AIDS Educ Prev; 1994 Apr; 6(2):113-25. PubMed ID: 8018438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV/AIDS services in private substance abuse treatment programs.
    Abraham AJ; O'Brien LA; Bride BE; Roman PM
    Drug Alcohol Depend; 2011 May; 115(1-2):16-22. PubMed ID: 21145179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing the effectiveness of a motivational interviewing-based brief intervention for substance use as an adjunct to usual care in community-based AIDS service organizations: study protocol for a multisite randomized controlled trial.
    Garner BR; Gotham HJ; Tueller SJ; Ball EL; Kaiser D; Stilen P; Speck K; Vandersloot D; Rieckmann TR; Chaple M; Martin EG; Martino S
    Addict Sci Clin Pract; 2017 Nov; 12(1):31. PubMed ID: 29149914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linking HIV-positive jail inmates to treatment, care, and social services after release: results from a qualitative assessment of the COMPASS Program.
    Nunn A; Cornwall A; Fu J; Bazerman L; Loewenthal H; Beckwith C
    J Urban Health; 2010 Dec; 87(6):954-68. PubMed ID: 21046470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence intervention for HIV-infected persons who use drugs: adaptation, open trial, and pilot randomized hybrid type 1 trial protocol.
    Claborn K; Becker S; Operario D; Safren S; Rich JD; Ramsey S
    Addict Sci Clin Pract; 2018 Apr; 13(1):12. PubMed ID: 29606129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applying behavioral activation to sustain and enhance the effects of contingency management for reducing stimulant use among individuals with HIV infection.
    Mimiaga MJ; Closson EF; Pantalone DW; Safren SA; Mitty JA
    Psychol Health Med; 2019 Mar; 24(3):374-381. PubMed ID: 30211620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triple diagnosis: dual diagnosis and HIV disease, Part 1.
    Douaihy AB; Jou RJ; Gorske T; Salloum IM
    AIDS Read; 2003 Jul; 13(7):331-2, 339-41. PubMed ID: 12889451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health care services for HIV-positive substance abusers in a rural setting: an innovative program.
    Wood SA
    Soc Work Health Care; 2008; 47(2):108-21. PubMed ID: 18956503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Illicit drugs, alcohol, and addiction in human immunodeficiency virus.
    Samet JH; Walley AY; Bridden C
    Panminerva Med; 2007 Jun; 49(2):67-77. PubMed ID: 17625483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementing comprehensive prevention of mother-to-child transmission and HIV prevention for South African couples: study protocol for a randomized controlled trial.
    Jones D; Peltzer K; Weiss SM; Sifunda S; Dwane N; Ramlagan S; Cook R; Matseke G; Maduna V; Spence A
    Trials; 2014 Oct; 15():417. PubMed ID: 25348459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving treatment adherence in drug abusers who are HIV-positive.
    Malone SB; Osborne JJ
    Lippincotts Case Manag; 2000; 5(6):236-45; quiz 245-7. PubMed ID: 16398004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contingency management interventions for HIV-related behaviors.
    Haug NA; Sorensen JL
    Curr HIV/AIDS Rep; 2006 Nov; 3(4):154-9. PubMed ID: 17032574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlates of HIV-related risk behaviors in African American adolescents from substance-using families: patterns of adolescent-level factors associated with sexual experience and substance use.
    Fisher HH; Eke AN; Cance JD; Hawkins SR; Lam WK
    J Adolesc Health; 2008 Feb; 42(2):161-9. PubMed ID: 18207094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.